“agios-pharmaceuticals” Archives

in
Entry Author Date Location
Foundation Medicine Lays Groundwork For $86M IPO 07/29/13 Boston
East Coast Life Sciences Roundup: Sarepta, Agios, Gerngross, & (Much) More 07/26/13 Boston
Agios Rockets to $29 Per Share in Market Debut 07/24/13 Boston
Agios Prices Upsized IPO Above Range, Preps For Nasdaq Debut 07/24/13 Boston
The Biotech IPO Phenomenon of 2013: Enjoy It While It Lasts 07/22/13 National
Trusting Your Partners: A Chat With Celgene’s George Golumbeski 07/11/13 New York
Bluebird Prices Ahead of Range, Takes Flight on Nasdaq Today 06/19/13 Boston
East Coast Life Sciences Roundup: Agios, Ludwig/CRI, Celgene 06/14/13 Boston
Agios Files For IPO With Plans to Raise $86M 06/11/13 Boston
Forma Strikes $200M Deal With Celgene to Discover Cancer Drugs 04/29/13 Boston
A Biotech Innovation Supply Chain: Reality or Fantasy? 04/22/13 National
Syros, a Whitehead and Dana-Farber Spinoff, Snags $30M For Cancer 04/11/13 Boston
Third Rock Stocks Up With $516M New Fund, Looks to Start 16 Cos 03/25/13 Boston
Presage Snags $13M from Celgene to Pick Winning Cancer Drug Combos 03/05/13 Seattle
Third Rock’s Bet on Lotus Tissue Repair Generates Big Return 02/27/13 Boston
Watch Out SF, Boston Is Turning Into Biotech’s No. 1 Cluster 10/08/12 National
Constant Contact, Bluefin Labs, HP, & More Boston Dealmakers 01/25/12 Boston
Forma Reels In J&J With $700M Deal; 2nd Cancer Drug Discovery Partner in a Week 01/10/12 Boston
Aileron Expands Roche Deal, Agios Gets $78M, Genzyme MS Drug Advances, & More Boston-Area Life Sciences News 11/18/11 Boston
Agios Pharmaceuticals Obtains $78,000,000 Series C Round 11/17/11 Boston
Tolerx Shutters, Courtagen Gets $8M, OvaScience Emerges, & More Boston-Area Life Sciences News 10/14/11 Boston
Courtagen Grabs $8M, Nuance Buys Swype, OpenView Eyes Expansion Stage Investments, & More Boston-Area Deals News 10/12/11 Boston
Celgene Pays Agios $20M, Lycera Adds Cambridge CEO, Getinge Buys Atrium Medical, & More Boston-Area Life Sciences News 10/07/11 Boston
Agios Pulls in $20M From Celgene, Under Extended Cancer Metabolism Partnership 10/05/11 Boston
Genentech Scoops Up Tumor-Starving Drug Program From Forma Therapeutics In Rare Deal 06/27/11 Boston
Forma, After Building Cancer Drug Discovery Engine, Makes First Big Bet on Starving Tumors 03/10/11 Boston
Third Rock Ventures Secures $426M Second Fund, Makes Changes to Partner Ranks 09/13/10 Boston
Biogen Strikes Deal with Knopp for ALS Drugs, Selecta Gets New CEO, Avantra Scores $7M, & More Boston-Area Life Sciences News 08/20/10 Boston
Agios, Nourished with $130M Celgene Deal, Expanding Staff and Labs to Starve Cancer 08/19/10 Boston
Third Rock Ventures, Firm With Hunger for Audacious Biotech Ideas, Sets up SF Shop 08/12/10 San Francisco
Page 3 of 4 « previous page · next page »